Seamless GMP Cell Separation: Healthier Cells, Better Therapies. Akadeum’s microbubble technology is the first GMP cell separation modality to solve all the challenges in the early steps of the cell therapy manufacturing process: time, cost, scalability, and performance. Microbubbles are flexible to integrate into any workflow and provide an increase in potency and persistence while enabling up to a 40% reduction in overall cell therapy manufacturing costs. Compatible with both centralized and decentralized manufacturing models, utilizing microbubbles for cell separation is the path to greater access and more cost-effective therapeutics. Healthier Cells. Better Therapies. Microbubble Cell Separation, Cell Therapy, and …

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Bioceltix is changing the veterinary therapy standards. We develop innovative biopharmaceuticals based on stem cells. Bioceltix is a Wrocław-based and internationally oriented biotechnological company developing innovative, both stem cells and secretome based products, for companion animals. Our flagship technology for manufacturing biopharmaceuticals for veterinary use utilizes the therapeutic potential of allogeneic stem cells (one donor – many recipients). Owning a GMP production facility, we provide single technology for several species, diseases, and routes of administration. Our cutting-edge approach will allow the product to be batch-produced and ready for off-the-shelf sale. The veterinary medicines, based on the immunomodulatory mechanism of action …

231 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Using mesenchymal stem cells to produce therapeutically meaningful extracellular vesicles. We are a recently incorporated limited company, spun out from the University of York from the Genever lab (www.geneverlab.info), which has over 20 years of experience in cell biology and regenerative medicine. We focus on musculoskeletal regeneration using mesenchymal stem cells (MSCs), with a view to translate our body of work into cutting edge therapeutics. Our current focal point is the field of extracellular vesicles (EVs), which have recently gained substantial traction as a next-generation therapeutic modality. We believe that current approaches have room for improvement in terms of consistency …

93 similar entities Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology

We see the future in cells CellVoyant is an AI-first biotechnology company building platforms for predictive cell analytics and AI-guided process optimisation. In cell-based development, decisions are often made too late, and unpredictable cell behaviour makes manufacturing complex, costly, and difficult to scale. As a result, promising development programmes can fail when processes lack predictability and control. Using standard, label-free microscopy images, our technology infers cell state and anticipates future performance—bringing quantitative insight earlier in the workflow and enabling more reliable optimisation. Our product ecosystem includes FateViewTM, a cloud-based platform for predictive cell analytics, and FateDriveTM, an AI-guided optimisation service …

72 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

Advancing Cancer Treatment Breakthroughs Carcinotech provides comprehensive solid tumor research services to advance drug development and enhance personalized therapy decisions. At the heart of its offerings is the proprietary Carcino3DTM bioprinting technology, which creates assay-ready, 3D tumors derived from patient biopsies. This innovative, translational approach delivers a predictive in vitro model, generating critical insights into therapeutic efficacy, and treatment optimization. Cancer research, 3D bioprinting , Cancer microenvironment, drug testing, oncology, assay services, oncology pre-clinical services, solid tumours, solid tumors, tumour microenvironment, tumor microenvironment, early phase drug development, and early drug discovery

274 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Expert services in supercritical CO2 and nanomedicines for the life science industry StaniPharm is a Contract Development and Manufacturing Organization (CDMO). Pioneers in supercritical CO2 technologies, we operate a state-of-the-art facility and provide the life science industry with flexible development and GMP manufacturing services. We move your products from idea to market: botanical extracts, challenging polymers and lipids, nanomedicines, tailored drug particles. Keywords : nanoparticles, medicinal cannabis, particle and crystal engineering, crystallization, polymers, lipids, supercritical fluids, purification, formulation, impregnation, sterilization, GMP manufacturing, poorly soluble drugs, polymorphism, CDMO drug delivery, supercritical fluids, formulation, nanoparticles, GMP manufacturing, poorly soluble drugs, sterilization, impregnation, …

70 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Transform how you model human biology. Ricoh Biosciences is a global leader in biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human biology and accelerating …

91 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

less complexity. more biology. At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis

931 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Revolutionizing Cell Therapy with Protein Design Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLastTM), recruit a productive immune response in the tumor microenvironment (OutSmartTM), and achieve the potency (OutSpacersTM), specificity (Co-LOCKRTM), and safety (EGFRoptTM) necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of …

61 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

‘Off-the-Shelf’ Curative Cell Therapies About Us: Cell BioEngines is a US-based clinical-stage biotechnology company developing off-the-shelf allogeneic cell therapies by chemically reprogramming stem cell fate and function to treat serious and currently incurable diseases. Leveraging cord blood stem cells from highly compatible 'super-donors' and powered by its proprietary STEM-Space cellular reprogramming platform, the company delivers scalable cell products with reduced risk of immune rejection. Cell BioEngines’ competitive edge comes from a unique combination of a transgene-free scalable manufacturing platform enabled by advanced chemical reprogramming, rigorous HLA-guided design, and a population-informed biobank that supports broad patient coverage. Cell BioEngines lead clinical …

311 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

For the love of the child. With the power of science. Vita 34 is the pioneer and market leader in cell banking in Europe. In over 28 years of company history, we have stored over a million cell preparations and supported the therapy of over 7,000 people. The FamiCord Group is on an exciting journey as we integrate several smaller European companies with decades of tradition and established local market positions into a strong international group. We want to continue our growth in the next few years by expanding our core business of stem cell storage from umbilical cord blood, …

78 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Seed Therapeutics is pioneering the science of improving human health by creating “molecular glues”: novel therapeutics that degrade disease-causing proteins that have heretofore remained “undruggable.” Through ongoing collaborations with world-leading academic experts in the field, and in partnership with seasoned drug development and commercialization experts, Seed Therapeutics is establishing a growing pipeline of exciting drug candidates on a path to clinical and commercial success. Our mission is to positively impact human health by creating novel protein degradation therapeutics for the treatment of severe diseases for which health care professionals currently have limited options to offer to patients. Biotechnology, Biotherapeutics, Cell …

201 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Pioneers in complex formulation · Ascil Biopharm is a clinical-stage biotechnology company specializing in innovative drug delivery solutions. We operate as a CDMO, fully equipped for early-stage drug product development, with a GMP facility for clinical batch manufacturing, (aseptic process and terminal sterilization) to fill various containers (e.g. vials, syringes). Our capabilities extend to formulation, device, and analytical development. · Our proprietary Controlled-Release Formulation (CRF) platform technology, is designed to improve the Phy-Chem properties of APIs and excipients under injection conditions, enabling the development of ready-to-use (RTU) controlled-release formulations and ultra-high concentration (UHC) drug products. · Our expertise covers a …

141 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

Visionary science. Every day human tissues are thrown away after surgery. At CTIBIOTECH we save them and give them new purpose, To advance human therapies, to develop new medicines, to test cosmetics or test anything that comes into contact with us. For a better human world. Founded in 2009, we have laboratories in Lyon, France and Philadelphia, USA. We have 4 wings to our company: CTIBIOSOURCING - providing human tissues, cells and culture media globally. CTISKIN - the world's most advanced manual and 3D Bioprinted human skin models for drug, device and cosmetics testing. CTIPHARMA - sophisticated human tissue models …

98 similar entities Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology

Explore Understand Innovate LBTI is a leading French research laboratory specializing in the study of healthy and diseased tissues and in the development of innovative therapeutic strategies with high potential for translation toward clinical applications. We have strong expertise in human skin, cartilage and mucosae. Our specific research aims are: > to analyze the basic mechanisms of tissue organization and homeostasis, and to identify potential therapeutic targets > to understand and model the tissue response to physiological or pathological stress (including mechanical stress and aging) > to develop novel therapeutic approaches for tissue repair and targeted delivery of therapeutic agents …

87 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Exploring together! We support biopharmaceutical research with translational preclinical models. CYNBIOSE is France-based non-clinical research organization. Preclinical CRO, Pharmacokinetics, POC, Efficacy, Immunotherapies, Drug, Early tox, CNS, Infectious diseases, Respiratory diseases, Non clinical, CRO, PK, PD, and TK

165 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, OXB has over 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB’s …

75 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Leading biotechnology company who supports scientists worldwide with high-end human cell culture products and services. At PromoCell, we help scientists do better research with a world-class portfolio of human primary, stem and blood cells as well as optimized cell culture media. With over 35 years of expertise, we are recognized globally for supplying scientists with the tools and support they need to do groundbreaking research. All our products comply with European biomedical conventions, ensuring human rights and donor privacy are always protected. Our ISO certifications demonstrate our absolute commitment to quality and our EXCiPACTTM GMP certification enables us to produce …

141 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Microbiology assays at previously impossible speeds and strain banks with amazing diversity ! Microbiology is what we do. Our unrelenting focus has enabled us to develop unique capabilities in ultra-high-throughput single-cell culture of microorganisms. Businesses in areas as diverse as pharma, agriculture, food, human health and environmental protection have partnered with us to gain powerful competitive advantages from our technology.So could yours. Our proprietary microfluidic platform is capable of : - identifying microbes of interest based on their functional characteristics among millions of candidates - perform a wide range of assays at previously impossible speeds - generate strain banks with …

144 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

A cell-therapy technology company developing artificial membrane-binding proteins for oncology and regenerative medicine CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation advanced therapies. Our novel cell membrane augmentation technology enables us to add new functionalities to various therapeutic cells. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health. Biochemistry, Immunology, Oncology, Regenerative Medicine, Cell therapies, and Proteins

121 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Superior and effective microbiome therapeutics CHAIN Biotechnology was founded in 2014, by serial entrepreneur Dr Edward Green, to exploit the therapeutic potential of Clostridia bacteria found in the human gut microbiome. CHAIN has built an impressive technical team of molecular biology, microbiology, microbiome and fermentation specialists focused on the biotechnology development of Clostridia. In addition, CHAIN leverages synthetic biology expertise from the Synthetic Biology Research Centre at the University of Nottingham. CHAIN has developed a proprietary microbial platform for drug delivery. The platform builds on core engineering skills and involves the development and use of engineered Clostridia to deliver specific …

61 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

OZ Biosciences creates, develops and commercializes life sciences reagents specialized in transfection and transduction OZ Biosciences is a product development company that creates, develops and commercializes delivery systems of bioactive materials (DNA, siRNA, proteins, antibodies...), intended for the worldwide scientific community and pharmaceutical industries. Our mission is to assist scientists to accelerate the rhythm of discoveries by offering them technologically advanced tools such as transfection reagents and other life science research products. Principal innovations are based on proprietary technologies such as Magnetofection (magnetic-assisted transfection or infection), Magneto-Biolistic, transfection reagents, transduction tools, mRNA and lipids-based delivery systems (LNP). Specialized and expert …

90 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Portuguese start up developing a relevant position across the product and business value chains of cellular agriculture. We are kickstarting Cell-Based Agriculture in Portugal. Our team aims to create a network of businesses that will lead the market in the next decade driven by technical knowledge on Cell-Based protein production.

62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Enabling manufacture of cell therapies at scale Cell therapy manufacturing was never designed to scale. Cellular Origins is changing that. We enable the manufacture of cell therapies at commercial scale through a flexible, factory-led approach. Our platform, Constellation, combines mobile robotics and AI to orchestrate the movement of patient material, equipment, and processes across the entire facility, while integrating with your leading bioprocessing technologies. By replacing fixed, linear systems with modular, parallelisable design, we enable intelligent capacity planning, built-in redundancy, and seamless scale-up without process redesign. The result is lower risk, greater efficiency, increased flexibility, and a faster path to …

111 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Built on Trust. Driven by Science. Focused on You. BÜHLMANN Laboratories AG is a fully independent, mid-sized Swiss company founded in 1976. With local teams in Switzerland, France, Italy, Germany, Austria, the USA, and Brazil, as well as distributors worldwide, BÜHLMANN has established itself as a leader in the field of specialty in-vitro diagnostics. Recent milestone: On June 5, 2024, BÜHLMANN was acquired by KLAR Partners to support the company's continued growth. BÜHLMANN has quickly become a leading provider of calprotectin tests, offering the broadest range of available solutions, including fully automated, high throughput turbidimetric and ELISA assays (BÜHLMANN fCAL® …

76 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

For when you need it all. We're here. For when you need it all. We're here. We know scientists give it their all every day to reach their goals. Wherever your research takes you, Proteintech provides all of the antibodies you need to help you do that. All types and forms of antibodies are in stock for your experiment. We’ll be there for every step of your journey. With our GMP capabilities and recombinant custom antibody platform, we can provide the support to scale up from bench to clinic. Search the full catalog at ptglab.com. Whole Protein Antigen Antibodies, Polyclonal …

71 similar entities Type: SMB Activities: biotech deeptech legaltech Technologies: Synthetic Biology

VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to …

75 similar entities Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

We make the development of modern therapies faster, safer, and more affordable. Join us to create the future of health! We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other …

123 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Expertise that matters Mercodia is a Swedish life science company and experienced bioanalytical CRO with over 30 years in the field, specializing in analytical solutions for large molecule therapeutics and biomarkers. We develop and manufacture high-quality immunoassays for research and clinical diagnostics, with a core focus on biomarkers for diabetes, obesity, and cardiometabolic diseases. From our GLP-compliant laboratories in Europe and the US, we provide cost-effective bioanalytical services spanning preclinical to clinical phases of drug development programs. We support pharmaceutical, biotech, and academic teams by ensuring regulatory compliance while optimizing cost and efficiency. Renowned for our reliability, scientific expertise, and …

89 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Accelerating biomedical research by connecting biopharmas with the right preclinical cancer models and CRO partners Repositive is committed to accelerating the development of precision cancer therapies to the clinic by working with biopharmas and Contract Research Organisations (CROs) to improve the predictivity of pre-clinical cancer research. Through its Cancer Models Scout service, Repositive is helping biopharmas to optimise their pre-clinical cancer projects by identifying the most suitable cancer models for their requirements from its world-leading database of over 8000 models, as well as via outreach to an extended network of CRO contacts. Repositive works to connect researchers with the right …

130 similar entities Type: Startup Activities: biotech it services deeptech Technologies: Synthetic Biology

HELPING CREATE A HEALTHIER WORLD THROUGH EXCELLENCE As CDMO (Contract and Development Manufacturing Organization), BePharBel Manufacturing contributes to improve the health of all by supplying our pharma partners: - a genuine end-to-end development and manufacturing solution - that facilitates and accelerates drugs availability for patients. Our main activities are: 1) CDMO BePharBel Manufacturing provides an integrated end-to-end solution for the development and manufacturing, under European GMP conditions, of drugs (small molecules and antibiotics) and medical devices. Our expertise field is the development of new formulations and drug formulations over more than 10 different sterile and non-sterile galenic forms (injectables, powder …

102 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Where Molecule Becomes Medicine — First-Time-Right | Solid-State, Preformulation, Formulation & GMP Manufacturing Crystal Pharmatech is a science-led CRO/CDMO for small molecule drug development — from solid form selection and preformulation through formulation development and GMP clinical supply. Since 2010, we have supported more than 4,000 compounds for pharmaceutical and biotechnology partners worldwide. We start with solid form science. Polymorph, salt, and cocrystal screening, crystallization process development, and developability assessment establish — from data rather than assumption — whether a molecule will succeed as a crystalline solid or requires an enabling formulation. Our containment capability extends this work to highly …

150 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

BioCopy is a Swiss-German biotech company with headquarters in Basel and a state-of-the-art R&D facility in Emmendingen, Germany. The company focuses on drastically accelerating the development of safe and effective next-generation cancer drugs to improve the chance of a cure significantly. BioCopy combines artificial intelligence with its automated end-to-end engineering platform to create biotherapeutics with unrivalled efficacy and safety that are transforming the R&D process in today's pharmaceutical industry. The BioCopy platform generates data sets of high quality and quantity currently unmatched in the industry that are essential to leverage the potential of AI. This synergy reduces the research and …

402 similar entities Type: Startup Activities: deeptech Technologies: A.I. Synthetic Biology

High quality and novel growth factors for stem cell and organoid culture, regenerative medicine and cellular agriculture Qkine manufactures high-quality and novel growth factors, supporting scientists in developing and scaling stem cell, organoid, cellular agriculture and regenerative medicine applications. We are also developing new growth factor technologies to enable emerging fields such as cultured meat and 3D cell culture. All Qkine high purity animal-free growth factor proteins are manufactured at our facility in Cambridge, UK . Extensive quality testing is conducted on every lot to guarantee reproducibility. Based on proprietary technology developed in the laboratory of Dr Marko Hyvönen, senior …

58 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Integrated CDMO & Consultancy | Cell & Gene Therapy Experts | From CMC Strategy to GMP Manufacturing & Facility Design eXmoor Pharma is the only integrated UK cell and gene therapy CDMO with consultancy expertise embedded at every stage of your journey, from early-phase strategy through GMP manufacturing to commercialisation. For over 20 years, we have provided specialised CMC consulting, process development, and GMP clinical manufacturing to more than 170 clients. Our industry-leading scientists and strategists help biotech and pharma companies accelerate innovation while reducing risk and costs. Our purpose-built process development and GMP manufacturing facility offers end-to-end solutions across …

168 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Let's Build Better Cells Together At MaxCyte®, we are committed to building better cells together. As a leading cell-engineering company, we are driving the discovery, development and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation® technology and SeQureTM gene editing risk assessment services enable high-performance cell engineering and rigorous evaluation of editing outcomes, supporting confidence in therapeutic development. Supported by expert scientific, technical and regulatory guidance, our platform empowers researchers to engineer diverse cell types and payloads, accelerating the development of safe and effective treatments for human health. For more than 25 years, we’ve been advancing cell engineering, shaping …

334 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Transforming research through technology Sophion was founded in the year 2000 by a group of passionate electrophysiologists, all having the shared purpose of making patch clamping objective and independent of user skills to provide faster, more accurate and objective patch clamping results. “To take the voodoo out of patch clamping”. Over the past twenty years, we have developed from a startup into a global organization, but the passion and drive to provide high-performance patch clamp solutions persist. With our complete technical, biological and application support we help our partners to achieve their targets, and through the continued development of our …

66 similar entities Type: SMB Activities: deeptech Technologies: Data Analytics Synthetic Biology

Customized Bioprinting systems and Bioreactors. Creating Life Changing Futures. REGEMAT3D develops customized Bioprinting Systems and Bioreactors - BMAP. We create Living Tissue Technologies. The potential of bioprinting in regenerative medicine and tissue engineering is huge. There are still many problems to be solved and many hypothesis to be tested in order to find solutions to tissue regeneration. Our mission is to develop innovative solutions in the area of bioprinting and regenerative medicine towards the clinical application of this amazing technology, to improve people ́s quality of life. bioprinting, regenerative medicine, biotechnology, and tissue engineering

71 similar entities Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology

A Precision Fermentation Company At Livzym, we are visionaries in precision fermentation since 2014, dedicated to delivering sustainable, high-impact solutions that drive innovation across industries. Our expertise in microbial engineering and large-scale production enables us to create environmentally friendly, scalable products tailored to diverse industrial needs. Our core business is producing high-performance enzymes—one of the most advanced applications of precision fermentation. Leveraging cutting-edge biotechnology, we engineer enzymes that power a wide range of industries with efficiency, reliability, and sustainability. We excel in scaling fermentation from lab to large-scale production, ensuring a seamless transition from concept to commercialization. Our platforms provide …

54 similar entities Type: Startup Activities: deeptech Technologies: Decarbonization

Innovative Manufacturing Services (IMFS).

176 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees …

258 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

ENABLING TECHNOLOGY FOR THERAPEUTICS TARGETING MEMBRANE PROTEINS G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation. We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform. G.Mixes® G.Select® Assay G.Lipidomics® G.Validation® Assay We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization …

61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

FAST LABORATORY DIAGNOSTICS OaCP, Oncology and Cytogenetic Products, deals with the creation of chemical and biotechnological products for fast diagnostics. We believe that the quality of work in molecular biology and molecular cytogenetics is fundamental, that it can also be economical (Smart-ISH Solve) and - why not - rapid (Rapid-ISH Integra). Thanks to the multi-year research conducted with the University of Bologna, we have developed the DoMo Genetics line of reagents but we don't stop! Our mission is to provide faster, more budget-conscious and easier-to-use tools to the molecular biology laboratory professional, to improve the quality of life of cancer …

90 similar entities Type: Startup Activities: deeptech biotech

Revolutionizing healthcare with exosomes focusing on gastrointestinal, liver and kidney regeneration EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver. Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this …

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Leader in Integrated pest management; Expert in Biocontrol & Pheromones #nopesticides Molecule Custom Synthesis #CDMO M2I Vision : Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological crop protection and organic electronics (Re)design synthetic routes and industrial processes for « hard to make » molecules (core capability) Propose to our clients a one stop shop from specification to regulatory clearance (DMF, MA) by teaming up with R&D and marketing teams The company operates a R&D center rance and a cGMP manufacturing plant. M2I holds a portfolio of …

64 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Bio sourced materials

Acoustic Cell Processing Solution 🚀 Aenitis designs, develops, and markets sole-in-class acoustofluidic technology that makes cell and gene therapy manufacturing better, safer, and less expensive. By precisely controlling levitated cells with sound waves, our systems handle cells in full sterile conditions and radically increase productivity while preserving the native state of cells at every step of the engineering process. This technology enables gentle, non-invasive manipulation of cells at the millifluidic scale, allowing for the handling of tens of milliliters per minute. Such capabilities are critical for scaling applications from research to clinical and industrial use. 💡Today, we have achieved proof-of-concepts …

90 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Cellectis is developing life-changing product candidates to target and eradicate cancer cells. Cellectis is a global, clinical-stage biopharmaceutical company. As pioneers and innovators in our field, we are driven by a single mission: to develop breakthrough treatments for patients with unmet medical needs. With 26 years of expertise, we operate a best-in-class genome editing platform focused on immuno-oncology and gene therapy. By leveraging our proprietary gene-editing technologies, we engineer allogeneic CAR-T cells designed to recognize and eliminate cancer cells. Currently, our two lead clinical programs are evaluating therapies for B-cell acute lymphoblastic leukemia (B-ALL) and non-Hodgkin lymphoma (NHL). As a …

173 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Scientist-to-Scientist Fluofarma, a Porsolt company, joins drug discovery projects to bring tailored solutions in cell biology and high-content analysis. Specialized in assay design, the French preclinical CRO develops and performs cell-based assays and quantifies biomarkers in blood and tissues using different high-content imaging and flow cytometry technologies. Fluofarma's contract research services are based on the following capacities: CUSTOM BIOLOGICAL MODELS > Generation of primary cell cultures, cell lines, 3D spheroids > Development of multi-cell type culture systems in 2D & 3D > Preclinical and clinical samples : whole blood, solid tissues and tissue microarrays (TMAs) ADAPTATION & DEVELOPMENT OF CELL-BASED …

75 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

From research to patients: safer, smarter, faster. 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidates. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Our Three Pillars are: 1.Safety 2. Efficacy 3. Manufacturing These are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan of execution. We have implemented a human and customer centric organization to provide the best …

124 similar entities Type: Startup Activities: biotech deeptech fintech manufacturing regtech Technologies: Synthetic Biology

Innovative Process Solutions IPSOMEDIC is a pharmaceutical development company, specializing in innovation in the manufacturing of active pharmaceutical ingredients (APIs). Our objective is to give countries the possibility to reach their pharmaceutical independance. We design tailor-made processes for all stages of industrial production, to become cost efficient, environmental-friendly, and safe: - Continuous chemical reaction - Continuous purification - Continuous crystallization Innovation, Chemical processes, drug substance, and Continuous processes

89 similar entities Type: Startup Activities: manufacturing industry 4.0 Technologies: Synthetic Biology

Cell culture automation, affordable and easy to use, for R&D labs. Cell culture automation for R&D labs: Affordable, time-saving and easy to use. The Nestor automaton is a plug-and-play device able to culture cells in up to 10 flasks or multiwell plates. It is ultra-compact and portable, with a 2xA4 sheet footprint and a weight below 5 kg. Automate the most time consuming tasks in your cell culture processes, for an investment in the range of any other basic lab equipment (and get a return on your investment within 24 months only). biotechnology, automated cell culture, and 3D cell culture

68 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Your Cell-Therapy Specialized CDMO Cell-Easy is a CDMO specialized in Cell Therapy. We support biotech, pharma, and public institutions with GMP development and manufacturing. Our mission: accelerate your Cell Therapy’s path to market, with patient access as our priority. ATMPs are not conventional biologics — they are living drugs. Our team brings hands-on expertise in cell culture across all cell types, engineered or not, addressing challenges in development, GMP manufacturing, and QC. Beyond core CDMO services — process diagnostics, development, GMP production, cell banking, cryostorage, and delivery — we also support sourcing of human biological materials and clinical trial setup, …

200 similar entities Type: Startup Activities: biotech healthtech manufacturing Technologies: Synthetic Biology

Biomanufacturing services Naobios is a Contract Development and Manufacturing Organization (CDMO) providing bioprocess development and offering GMP production of clinical batches of BSL2/BSL3 viral vaccines, oncolytic viruses, viral vectors and human viral challenge agents. Naobios joined the Clean Biologics group in 2019. Having built up 20 years’ experience in bioprocess development, Naobios helps its clients to bring their drug candidates to the clinical stage as rapidly as possible – at the highest level of quality – whilst building on its technical know-how in scalable and industrial processes. With its adaptability and range of skills, the company can lead a project …

59 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology

We produce customised chemical proteins to help our bio-pharms partners to accelerate their projects. 🧪 X’PROCHEM is a biotech company who invented an advanced and proprietary ligation technology. We help our bio-pharma partners design and create therapeutic, vaccine and diagnostic proteins. Unlike recombinant fermentation we can produce proteins containing up to 400 amino acids, without isoforms, endotoxins, or biological contaminants. We co develop solutions with our partners to understand the real needs within the context. By working closely, we can adapt to changing needs and circumstances. protein, purification, synthesis, protein production, peptide synthesis, and life sciences

147 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Preclinical CRO in Hematological Cancers Diag2Tec is an expert preclinical CRO devoted to hematological cancers, especially Multiple Myeloma (MM). We focused on in vitro Drug Testing in Human Hematological Cancer derived Cell Lines and Primary Cells from patients with various Hematologic Malignancies (Multiple Myeloma, Diffuse Large B Cells Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Mantle cell Lymphoma, Chronic Lymphoid Leukemia...). With our 2 platforms : Drug Testing Services and ChimioFx, our mission is to provide efficient treatment solutions for patients suffering from Hematological Malignancies with Precision Medicine approaches. We support biotech and phamaceutical companies to focus their drug development on …

67 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Tailor-made recombinant proteins CytobodX is a CRO company based in Marseille, France. At CytobodX, we produce, purify and characterize soluble and membrane proteins using state-of-the-art technologies to meet the specific needs of your research. The originality of CytobodX is to be able to rapidly produce native membrane proteins by using an innovative technology. Membrane proteins are directly expressed and embedded on the surface of purified Extracellular Vesicles (EVs) and ready for downstream applications : Interaction or functional studies, structural characterization or antibody/nanobody generation. This technology allows CytobodX to guarantee optimal quality and stability of the proteins produced and marketed. contact: …

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a …

69 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Soft culture plates for pleased cells Cell&Soft is a young french biotech located in the AURA region, in Grenoble city. Born from a joint project between LTM Lab (CNRS) and CEA BIG, Cell&Soft is specialized in the development, production and sale of soft and biomechanical substrates for in vitro cell culture. Cell&Soft offers solutions to enhance the physiology and the relevance of cell culture and cell-based assays. biotechnology, cell culture, soft substrates, culture plates, cell-based assays, biotech, in vitro, drug discovery, stem cells, controlled rigidity, controlled stiffness, and petri dish

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

A new generation of flow-through instruments for solid-phase synthesis of peptide and oligonucleotide therapeutics. PeptiSystems offers a new generation of flow-through instruments for solid-phase peptide and oligonucleotide therapeutics synthesis. Based on flow-through column technology, our instruments are used within the biopharmaceutical and biotech industry for process development and large-scale GMP and non-GMP manufacturing. Chemistry first - our instruments are designed from a chemistry perspective to give maximum flexibility and control without compromise. Peptide Synthesis, Oligonucleotide Synthesis, Flowthrough column technology, Continuous flow, Organic chemistry, and Synthesis instruments

61 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

a NOVARTIS company CELLforCURE gathers all cell and gene therapies activities of the LFB group. With an annual production capability of several thousands of therapeutics batches, the Les Ulis CELLforCURE facility is the first modular entity in Europe to enable large scale industrial production for ATMPs. This platform operates on a mixed model of a CDMO (Contract Development and Manufacturing Organisation) providing large scale GMP and cGMP production services, for both clinical and commercial needs, and of a pharmaceutical company leading the development of cell and gene therapies medicinal products up to their launch on the market. CELLforCURE is an …

68 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

Now a part of Catalent Cell & Gene Therapy With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. …

60 similar entities Type: Startup Activities: deeptech manufacturing biotech Technologies: Synthetic Biology

Discover your favorite frequencies to boost your drug discovery business CellSine provides devices and software that make advanced electrochemical impedance spectroscopy easily accessible to any microbiological researcher. It delivers a platform tool for a that enables a wide variety of biochemical studies. Biotechnology, Cell culture monitoring, Proteïn - Proteïn interactions, Suspension cultures, Receptor signaling, Biofilm maturation, and T lymphocyte activation

380 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

IntBiotechnologies is an International Bio-medical Products Supplier and Consultant company founded by a research scientist, expert in clinical diagnostic and an international consultant. The company was born in recognition of the two principal needs: Laboratory services are an essential component of health services, requiring constant update and strengthening for improved clinical diagnostic, better testing, epidemiological surveillance, bio-medical research activities. The current and future needs of the biotechnology companies to provide to their customers an end users tested and approved customized products. IntBiotechnologies, LLC offers services to U.S. government agencies, state and local health departments, world wide state and governments, academic …

74 similar entities Type: Startup Activities: biotech deeptech

Cancer profiling for precision oncology and early cancer detection iCellate develops and provides cancer profiling services for precision oncology. iCellate’s CellMate® is a next generation circulating tumor cell (CTC)-based platform for cancer cell detection and comprehensive biomarker analysis. GeneMate® is an analysis for hereditary cancer and gBRCA testing. Cancer Diagnostics, Circulating Tumor Cells (CTC), Liquid Biopsy, Next Generation Sequencing, CDx, Hereditary Cancer, Early Detection, Cancer, and Solid Tumors

81 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

AYOXXA – the Translational Proteomics Company. Understanding complex biology from bench to bedside. AYOXXA - The translational proteomics company AYOXXA Biosystems GmbH, based in Cologne (Germany), is an international biotech company focused on the development of its proprietary beads-on-a-chip technology for advanced protein analysis. LUNARISTM. AYOXXA’s innovative multiplex protein analysis platform is a fully integrated system designed for the parallel analysis of multiple biomarkers in picogram amounts of biological samples, allowing scientists to gain a maximum of high quality and reproducible insights. LUNARISTM is fully scalable, with integrated, image-based quality control and transparent data processing and management, enabling translational proteomics …

84 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

CDMO Services (Research, Development and cGMP Manufacturing for Biologics) Bionova Scientific is a dynamic, full service, biologics Contract Development and Manufacturing Organization (CDMO) on a mission to deliver the highest quality process development and manufacturing services to biologic drug development companies around the world. Bionova’s renowned scientific expertise and dedication to its customers helps life changing therapies arrive to the market faster and more efficiently. At the heart of Bionova is a team of highly dedicated experts combining strong experience in cGMP biologics manufacturing and process development, with a technology-focused approach and a deep knowledge of the industry. From early …

60 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Fluid Management Equipment Built For You As a global partner to the biopharmaceutical industry, Asahi Kasei Bioprocess helps biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably supplying innovative yet exceptionally reliable bioprocess consumables, equipment and scientific support services. Our portfolio is anchored by PlanovaTM virus removal filters. First released in 1989 as the world's first hollow fiber filter developed specifically for removing viruses from biotherapeutic drug products, PlanovaTM filters ensure viral safety of biopharmaceutical drug products, thanks to their high quality and consistent performance. Leveraging 30 years of experience, we continue to provide our customers …

88 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

The CanVas platform is focused on developing novel cell therapies. The CanVas platform is spearheading the development of investigational allogeneic candidates for neurologic, rare and other serious diseases. Our world class team are dedicated to advancing a wave of investigational allogeneic products through excellence in translational research, clinical development and cell manufacturing. We are developing a pipeline of off-the-shelf cell therapies based on the pioneering Can-Vas platform. This could allow for the delivery of cell therapies to patients faster when they need it most and at greater scale. Our mission is to have a transformative impact on patients’ lives by …

245 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Facilitators of Life Sciences Research We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster:​ - We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance. ​ - We accelerate their Research thanks to our Contract Research Services’ …

134 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Your GMP Next-Gen Biosafety Partner Charles River Labs has acquired Pathoquest, strengthening its end-to-end biologics testing portfolio with Next Generation Sequencing (NGS). Our GMP-compliant, animal-free NGS assays for viral safety and genetic characterization enable a faster and safer release of biotherapies to patients. Pathoquest, A Charles River Company, is a global CRO specializing in NGS-based Biosafety Quality Control through its iDTECT® assay platform, enabling the rapid and safe release of biotherapies to patients. The company offers validated GMP assays for viral safety testing and genetic characterization of raw materials, cell and gene therapies, monoclonal antibodies, and vaccines. Our testing services …

74 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Helping you create human-relevant in vitro models! Imagine a world where your experiments are cutting-edge, yet straightforward to perform, analyze and interpret, experiments that are time-saving, more accurate and more physiologically relevant. All this so you can get results sooner and move closer to your goal. This world is our vision! We’re committed to developing next-generation technologies for you. Powered by scientists, we design and produce innovative microfabricated devices with feature-sized components that match the dimensions of biological cells, so that you can take full advantage of emerging cell culture technologies, such as stem cells & 3D culture systems. These …

114 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Science-driven CDMO empowering biopharma, from R&D breakthroughs to commercial success, with you at the core. Olon France is a leading contract development and manufacturing organization (CDMO) specializing in tailor-made process development and manufacturing for biologics, antibody–drug conjugates (ADCs) and nanomedicines. Based in France with state-of-the-art, GMP-certified facilities, we partner with biopharma innovators at every stage of their journey — from early R&D and clinical-scale production through to commercial supply. Our multidisciplinary team brings deep scientific expertise, agile project management and rigorous quality systems to accelerate timelines, optimize processes and de-risk scale-up. As part of the Olon Group, Olon France combines …

71 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Accelerate Biotechnology Batavia Biosciences is a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies. We are not your standard CDMO - our customers regularly refer to us as their product development partner and thought partner. We focus on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization to clinical manufacturing. Headquartered in Leiden, The Netherlands, Batavia Biosciences is privileged to have strong strategic partners in …

132 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Innovations from Nature The Austrian Centre of Industrial Biotechnology (acib) replaces conventional industrial processes by new, more ecological and economical methods that are adopted from nature. Therefor acib can rely on 30+ years of experience and a network of 180+ mostly longterm international scientific and corporate partners and 200+ researchers in the multiple disciplines of industrial biotechnology and bioengineering. The acib network meets the needs of of the biotechnological, chemical and pharmaceutical industry and is the preferred partner for competitive research in industrial biotechnology – focused on biocatalysis, enzymes and (pharmaceutical) protein production. acib partners get access to innovative scientific …

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Cell therapy Acceleration and Innovation: Rethinking cell & gene therapy By Institut Curie CellAction (Cell therapy Acceleration and Innovation) is the cell and gene therapy platform of the Paris-Saclay Cancer Cluster (PSCC) at Institut Curie. A first in France, CellAction enables collaborative projects to be launched with industrial partners on a national and international scale. The aim is to accelerate the development of optimized cell and gene therapies. CellAction is founded on the centralization of key expertise required for the drug development process: - Institut Curie's highly qualified medical-scientific teams - Cutting-edge technologies for in vitro and in vivo testing …

69 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Founded in 1951 by pharmacists and microbiologists, biose® has 60-year experience in drug based on live bacteria, giving us a deep understanding of the entire process from discovery to commercialization. Focused on Health through microbiota and microbiome science, we use our skills for the discovery, product development, clinical studies and manufacturing of Live Biotherapeutic Products (LBPs). Our company is drug-GMP certified for the manufacturing of bacteria-based APIs, clinical and commercial products. Microbiome Therapeutics, live biotherapeutics, LBPs, and CDMO

127 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Next generation quality control for cell therapy Stem Genomics provides dedicated services to assess the genetic integrity of human stem cells. We help research scientists with specific assays and recommended workflows for the cell type they work with. Our flagship testing solution, iCS-digitalTM PSC, has revolutionized in-process genomic stability testing in hPSCs thanks to its high precision, ease and speed. It is particularly interesting for regularly monitoring stem cell lines in culture as well as for screening large numbers of clones, e.g., CRISPR-edited clones or human iPSC clones after reprogramming. We can also perform the following tests for you: G-Banding …

67 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Where Proteins and Innovation Advance Biomedicine ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England, Germany, and China. ACROBiosystems Group has established numerous long-term and stable partnerships with the world’s top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes. The company comprises of several subsidiaries such as …

93 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Gain actionable insights to confidently advance every step of your oncology drug development programs. Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. We provide novel insights, expertise and capabilities that empower our biopharmaceutical partners to confidently advance every step of their oncology drug development programs. precision medicine, Biopharma, biomarker signatures, and Cancer care

107 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Data Analytics

PROTEIN EXPRESSION ON YOUR TIMELINE | produce proteins in hours, not months ALiCE is a universal protein expression platform for teams who can't wait. Made for AI-designed and complex proteins, ALiCE can produce full length proteins, with eukaryotic modifications, within hours. If you are: - Stuck waiting for wet lab data to feed into your model - Working with complex, toxic, or non-natural proteins - Fed up of testing multiple cell lines and expression systems Get in touch with LenioBio to learn more about how ALiCE can support you Protein Expression, Protein Production, Synthetic Biology, Biotechnology, Membrane proteins, Antibodies, Functional …

59 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: A.I. A.I. - Machine Learning Bio sourced materials Synthetic Biology

CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates. CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism. High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, and muscle health

62 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unlocking the promise of biomanufacturing by transforming the economics of production with our patented FAST bioreactor DAB.bio develops and deploys cutting-edge fermentation technology. Our unique and patented FAST platform (Fermentation Accelerated by Separation Technology) enables continuous fermentation with cost reductions of 20-50% or more and is one of the most significant fermentation innovations of the past decade. The global focus on synthetic biology has delivered breakthrough routes to replace fossil-based chemicals with sustainable bio-based alternatives. High manufacturing costs currently hamper the large-scale manufacturing of many of these alternatives. FAST addresses this issue head-on. It is the largest contributor to lowering …

72 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

We create all-in-one instruments that make high-throughput single-cell workflows easy thanks to droplet microfluidics At LiveDrop, we develop, build, and sell cutting-edge instruments and methods for high-throughput screening of biological cells and organisms—down to the single-cell level—using microfluidic droplets. Our solutions enable faster, more precise screenings through highly efficient, fully integrated bioassays. LiveDrop’s flagship platform, ModaFlow 4L5C, revolutionises cell screening, drug discovery, and secretome analysis with unparalleled speed and precision. It supports a wide range of applications, including monoclonal antibody discovery, single-cell secretome-based bioassays, high-throughput spheroid manufacturing for drug testing, directed evolution of microbes, and enzyme discovery. We value collaboration …

343 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

European Mammalian CRDMO - From Discovery mgs to Clinical GMP kgs. Icosagen is a unique European CRDMO, being successfully in the business for more than 26 years as an independent family-owned company. As such, we combine pre-clinical CRO and clinical CDMO development expertise at one single site for therapeutic antibodies, multispecifics, ADCs, and other complex recombinant protein drug candidates. As a CRDMO we discover, develop, and manufacture proteins seamlessly from research concepts into pre-clinical and clinical development stages. This includes everything from small-scale transient productions to stable high producing cell lines, to manufacture clinical GMP materials in our modern 200/1000L …

71 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Identify and quantify your Host cell proteins thanks to our HCP profiler solution! #TechnologicalCRO #HCP ANAQUANT provides pharmaceutical and biotech companies with high quality services in detection and quantification of proteins by mass spectrometry, in order to speed up their R&D. Thanks to its unique know-how in control and validation of protein quantification, ANAQUANT is a partner of choice for customized assay development of proteins. Our expertise in performing specific and sensitive assays – from one to several dozens of proteins in a small sample volume – significantly contributes to the success of discovery and validation of biomarkers. Our proprietary …

75 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The glyco design company Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved. Bioproduction and Cell …

84 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Making it possible CLEAN BIOLOGICS is a CDMO for Viral vectors, Viral vaccines and oncolytic viruses and Biosafety testing for biological products. As well as a CMO for MCB & WCB production. GMP compliance

95 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech

385 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Harnessing natural messengers for innovative therapeutics Ciloa is a pioneer in the bioengineering of extracellular vesicles to develop new generations of therapeutics and preventive solutions to improve patients' lives. Ciloa bioengineers sEV proteins, to turn them into natural messengers with huge medical potential. Our bioengineered sEVs can be used as therapeutic solutions in a number of medical fields, including oncology, metabolic diseases, rare diseases and age-related illnesses. Mastering sEV engineering, we have produced sEVs containing a stable, highly multimerised and functional adiponectin (APN), a hormone well known as our “Guardian Angel” for its insulin-sensitizing, anti-inflammatory and anti-oxidative stress properties. Ciloa’s …

61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Which molecule will stand out INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to anti-cancer treatment evaluations and early toxicity studies. Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage. This breaking-thought technology, based on chick embryo, provides early analysis of your treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities. This next generation of in vivo efficacy …

79 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A stem cells Contract Development and Manufacturing Organisation (CDMO) in Singapore. MSC, iPSC, clean meat. SingCell offers process development and contract manufacturing services for stem cell therapy and clean meat companies. SingCell leverages its proprietary technology to improve manufacturing processes and offer high consistent quality stem cells. #cleanmeat #celltherapy

60 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Media additives to enhance cell culture systems I IP sold to C-LEcta in Sep 2025. CellRev developed a range of proprietary bioprocessing enzymes to increase yield, improve process consistency, and deliver better manufacturing outcomes. The IP was sold to C-LEcta in September 2025. Bioprocessing, Adherent Cell Culture, Process Engineering, Cell Biology, Cell Growth, and High-Density Processing

109 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing. As a trusted partner for biotech and pharmaceutical companies seeking to advance clinical trials and commercialize new Advanced Therapy Medicinal Products (ATMPs), Yposkesi offers a full range of services in lentiviral vectors and AAV (Adeno-Associated Virus) cGMP manufacturing. Within its current 50,000 ft2 (approx. 5,000 m2) facility, Yposkesi operates multiple manufacturing suites for bulk drug substances (up to 1,000 L) and fill and finish to support the growing demand for late-phase projects. In 2023, Yposkesi will bring online …

59 similar entities Type: Media SMB Activities: deeptech biotech Technologies: Synthetic Biology

Unlocking the potential of solid samples in the field of biological diagnostic Diagante develops a solution for in vitro diagnostics. Its platform allows the analysis of solid clinical specimen on rapid and high throughput instruments in clinical pathology labs. It provides faster results, enhanced personalized medical care, and lower costs to the stakeholders.

150 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Trustworthy development and commercial manufacturing of CELL&GENE therapies CELLforCURE by SEQENS, based near Paris, is a leader in the manufacturing of Advanced Therapy Medicinal Products (ATMPs), specialized in both autologous and allogeneic cell and gene therapy solutions. With over a decade of expertise, we provide comprehensive end-to-end services, from Phase I to full-scale commercial production. Our cutting-edge “one-stop-shop” facility spans 10,000 sqm, including 2,200 sqm of GMP-certified production areas and 7 independent manufacturing lines, each equipped with 8 cleanrooms, ensuring maximum safety and compliance for every product. As a trusted comprehensive solution provider, we facilitate seamless project development, leveraging in-house …

68 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology

Ready-to-use cell bank, for research, for patients Lymphobank - ready-to-use cell bank, for research, for patients. Lymphobank is a biotech company specializing in the supply of adult and placental blood cells for research use, the characteristics of which will be available online (www.lymphobank.fr), making it possible to choose the cellular product based on a donor of interest. Our services are focused on the development of cellular immunotherapy products. Furthermore, Lymphobank is developing an innovative allogeneic adoptive immunotherapy approach for hepatocellular carcinoma (the most common liver cancer and second cause of cancer death in the world, with nearly 750,000 deaths per …

70 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

CELLOMET provides cutting-edge R&D services on cellular metabolism for needs in industry and public institutions. CELLOMET is a spin-off CRO composed of internationally recognized experts in the field of cellular metabolism. Metabolism comprises crucial biological processes which enable breakdown of sugars, proteins, and lipids necessary to provide life-sustaining energy in all types of living organisms. CELLOMET has developed in-depth knowledge and cutting-edge technologies to address any particular metabolic modification occuring at the cellular level. This expertise can be applied to study the effects of pharmacological compounds or natural extracts in cosmetology, the impact of genetic modifications or nutrition, and the …

57 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Experts in industrial bioprocess optimization | Scalable microcarrier tech for advanced cell culture. 🔬 Industrial Bioprocess Optimization Experts | Enabling Scalable & Controlled Cell Manufacturing 🚀 At Carroucell, our expertise is built on years of dedicated R&D and strategic partnerships with leading cell producers 🤝. We have developed a groundbreaking microcarrier specifically designed for static environments, and our extensive experience supports the entire bioproduction chain—from initial project design to full-scale industrial manufacturing 🏭. Our flagship platform, FlexiGrow, is engineered using advanced sol-gel processes and bioinert glass. This technology not only delivers optimal cell adhesion, viability, and recovery but also sets …

59 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

We are now 3PBIOVIAN! Follow us on our new LinkedIn page, 3PBIOVIAN, to stay updated on all the latest developments and news! 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO. Read more here: www.3pbiovian.com ***** 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined …

95 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for …

110 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology